Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/ refractory multiple myeloma: a real-life experience

Abstract

We found RD to be safe, well tolerated, and effective in RRMM in everyday clinical practice in Turkey.

Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study

“…10 However, in the area of multiple myeloma-particularly in RRMM-, sociodemographic characteristics of study participants (aside from sex and age) are rarely reported, even in studies investigating these patients in the real-world setting. [15][16][17][18][19][20][21] Furthermore, most of these studies are focused on specific therapeutic agents, thus losing sight of the general profile of RRMM. Our analysis made it possible to provide an archetypal sociodemographic profile of RRMM patients in Spain, who are mostly men or women in their 60s or 70s, retired and living in an urban area with their relatives.…”